HEALTH

Carex Health Brands launches pair of new DME products

BY Michael Johnsen

NORWELL, Mass. — Carex Health Brands on Monday introduced two new items to its mobility lineup — the new Classic Wheelchair from Carex Health Brands and Carex’s Two Wheeled Walker with Seat and Backrest. 

The new wheelchair comes equipped with a large 20” seating area, fold-down back with storage pouch and adjustable swing away footrests. The wheelchair’s desk-height arms allow users to conveniently pull up to a table without disruption. The arms can be easily removed for side transfer and the entire wheelchair folds flat for convenient, compact storage and transport. Suggested retail price is $199. 

Carex’s new walker features oversized six-inch wheels and auto glide rear tips that double as an easy-to-use brake when pressed down for added safety. Height adjustable and with a lightweight frame that can support up to 300 pounds, the walker can be folded by lifting up on the seat for compact storage and transport. Suggested retail is $85. 


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Bausch + Lomb names new president, CFO

BY Michael Johnsen

ROCHESTER, N.Y. — Bausch + Lomb on Tuesday named Robert Bertolini as president and CFO effective immediately. In this capacity, he will oversee the company’s finance, information technology and global quality and operations functions. Bertolini, who assumes CFO responsibilities from Brian Harris, will report to Bausch + Lomb CEO Brent Saunders.  

"Bob Bertolini’s extensive strategic, operational and transformative leadership experience as a CFO of one of the world’s leading publicly traded healthcare companies will enable Bausch + Lomb to further unlock our potential and accelerate our performance," Saunders said. 

Bertolini previously was EVP and CFO at Schering-Plough from 2003 until its merger with Merck in 2009. During his tenure, Bertolini worked as a business partner with the CEO in all aspects of transforming the company’s operations. He had responsibility for key financial areas including tax, accounting and financial asset management, among other areas; built finance and information technology functions; and led business development and strategy.  

Earlier in his career, Bertolini spent 20 years at PricewaterhouseCoopers, ultimately becoming partner and leading the Global Pharmaceutical Industry practice.  

Bertolini earned his bachelor’s degree in economics at Rutgers and is a Certified Public Accountant. He is a current board member of Actelion Pharmaceuticals and Charles River Labs, and a former board member of Genzyme Corporation.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

HungerShield launches new appetite suppressant

BY Michael Johnsen

NEW YORK — HungerShield on Friday announced the launch of its appetite control product of the same name. The appetite suppressant is formulated with a blend of fiber, protein and probiotics and is designed to be mixed with 12-16 oz. of water to create a lemon-lime flavored drink that can be consumed on-the-go.

“With close to 70% of the U.S. population overweight or obese, and 95% of dieters gaining weight back within 1 to 5 years, HungerShield addresses a dieter’s biggest pitfall — appetite control — in a completely natural way,” stated Elizabeth DeRobertis, co-founder of HungerShield.

With only 40 calories, HungerShield contains 5 grams of protein and 4 grams of fiber along with whey protein, flaxseed powder and probiotics. 

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?